COMPASSION S3 Post-Approval Study
Public ClinicalTrials.gov record NCT04860765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Congenital Multicenter Trial of Pulmonic Valve Dysfunction Studying the SAPIEN 3 Interventional THV Post-Approval Study
Study identification
- NCT ID
- NCT04860765
- Recruitment status
- Active, not recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Edwards Lifesciences
- Industry
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Interventions
- SAPIEN 3 THV Device
Device
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 12, 2021
- Primary completion
- Jul 31, 2030
- Completion
- Jul 31, 2030
- Last update posted
- Feb 2, 2026
2021 – 2030
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Birmingham | Alabama | 35487 | — |
| Cedars Sinai | Los Angeles | California | 90048 | — |
| Children's Hospital of Colorado | Aurora | Colorado | 80045 | — |
| Advocate Childrens Hospital | Oak Lawn | Illinois | 60453 | — |
| Boston Children's Hospital | Boston | Massachusetts | 02115 | — |
| Minneapolis Heart | Minneapolis | Minnesota | 55407 | — |
| St. Louis Children's Hospital | St Louis | Missouri | 63110 | — |
| Newark Beth Israel Medical Center | Newark | New Jersey | 07112 | — |
| Mount Sinai | New York | New York | 10029 | — |
| Columbia University Medical Center/NYPH | New York | New York | 10032 | — |
| Duke University | Durham | North Carolina | 27710 | — |
| Cincinatti Children's Hospital | Cincinnati | Ohio | 45229 | — |
| Nationwide Children's Hospital | Columbus | Ohio | 43215 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 19146 | — |
| Dell Children's | Austin | Texas | 78723 | — |
| Children's Health Dallas | Dallas | Texas | 75235 | — |
| Primary Children's | Salt Lake City | Utah | 84108 | — |
| University of Virginia | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04860765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 2, 2026 · Synced Apr 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04860765 live on ClinicalTrials.gov.